Brita Danielson on Muck Rack

Brita Danielson

As seen in: Canadian Urological Association Journal
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Brita

Contact Brita, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

2025 Canadian Urological Association-Canadian Uro-oncology Group Guideline: Metastatic castration-naive and castrationsensitive prostate cancer (Update)

|
By Alan So, Kim Chi, Brita Danielson, Neil Fleshner
| Canadian Urological Association Journal Verified
You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association.
Open in Who Shared View Duplicates (5) Issue with article?

Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer | Canadian Urological Association Journal

|
By Bobby Shayegan, Brita Danielson, Fred Saad, Alan So
| Canadian Urological Association Journal Verified
Danielson, B., Saad, F., So, A., Morgan, S., Hamilton, R., Malone, S., Park-Wyllie, L., Zardan, A., & Shayegan, B. (2019). Management algorithms for prostate-specific antigen progression in prostate cancer: Biochemical recurrence after definitive therapy and progression to non-metastatic castrate-resistant prostate cancer. Canadian Urological Association Journal, 13(10). https://doi.org/10.5489/cuaj.5600
Open in Who Shared Issue with article?

Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence

|
By Fred Saad, Frederic Pouliot, Charles N. Catton, Brita Danielson
| Canadian Urological Association Journal Verified
Symptom assessment to guide treatment selection and determine progression in metastatic castration-resistant prostate cancer: Expert opinion and review of the evidence Multiple new agents to treat metastatic castration-resistant prostate cancer (mCRPC) have become available in recent years; however, the appropriate timing and sequencing of these agents have yet to be elucidated.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified